| Biological insights from 108 schizophrenia-associated genetic loci | Nature | 2014 | 5.2K |
| The World Health Organization Adult ADHD Self-Report Scale (ASRS): a short screening scale for use in the general population | Psychological Medicine | 2005 | 1.8K |
| Common schizophrenia alleles are enriched in mutation-intolerant genes and in regions under strong background selection | Nature Genetics | 2018 | 787 |
| Brain to plasma amyloid-beta efflux: a measure of brain amyloid burden in a mouse model of Alzheimer's disease | Science | 2002 | 495 |
| Serotonin transporter occupancy of five selective serotonin reuptake inhibitors at different doses: an [11C]DASB positron emission tomography study | American Journal of Psychiatry | 2004 | 399 |
| A randomized, double-blind, placebo-controlled trial of duloxetine in the treatment of women with fibromyalgia with or without major depressive disorder | Pain | 2005 | 344 |
| Comparative efficacy and safety of atypical and conventional antipsychotic drugs in first-episode psychosis: a randomized, double-blind trial of olanzapine versus haloperidol | American Journal of Psychiatry | 2003 | 335 |
| Lithium, a common drug for bipolar disorder treatment, regulates amyloid-beta precursor protein processing | Biochemistry | 2004 | 263 |
| Duloxetine in the treatment of depression: a double-blind placebo-controlled comparison with paroxetine | Journal of Clinical Psychopharmacology | 2004 | 235 |
| A genome-wide association study of anorexia nervosa | Molecular Psychiatry | 2014 | 224 |
| An integrated genetic-epigenetic analysis of schizophrenia: evidence for co-localization of genetic associations and differential DNA methylation | Genome Biology | 2016 | 189 |
| A double-blind, randomized comparison of the efficacy and safety of intramuscular injections of olanzapine, lorazepam, or placebo in treating acutely agitated patients diagnosed with bipolar mania | Journal of Clinical Psychopharmacology | 2001 | 184 |
| Current perspectives of the roles of the central norepinephrine system in anxiety and depression | Depression and Anxiety | 2010 | 169 |
| Quantification and mechanism of the fluoxetine and tricyclic antidepressant interaction | Clinical Pharmacology and Therapeutics | 1992 | 156 |
| Transient global forebrain ischemia induces a prolonged expression of the caspase-3 mRNA in rat hippocampal CA1 pyramidal neurons | Journal of Cerebral Blood Flow and Metabolism | 1998 | 145 |
| Involvement of a caspase-3-like cysteine protease in 1-methyl-4-phenylpyridinium-mediated apoptosis of cultured cerebellar granule neurons | Journal of Neurochemistry | 1997 | 144 |
| Gender differences in craving and cue reactivity to smoking and negative affect/stress cues | American Journal on Addictions | 2012 | 125 |
| Predictors of antipsychotic treatment response in patients with first-episode schizophrenia, schizoaffective and schizophreniform disorders | British Journal of Psychiatry | 2004 | 120 |
| Clinical Pharmacology and Pharmacokinetics of Fluoxetine: A Review | British Journal of Psychiatry | 1988 | 113 |
| The low density lipoprotein receptor regulates the level of central nervous system human and murine apolipoprotein E but does not modify amyloid plaque pathology in PDAPP mice | Journal of Biological Chemistry | 2005 | 104 |
| The effect of fluoxetine on the pharmacokinetics and psychomotor responses of diazepam | Clinical Pharmacology and Therapeutics | 1988 | 102 |
| α2-Macroglobulin as a β-Amyloid Peptide-Binding Plasma Protein | Journal of Neurochemistry | 2002 | 98 |
| Male-biased autosomal effect of 16p13.11 copy number variation in neurodevelopmental disorders | PLoS ONE | 2013 | 88 |
| Alpha2-macroglobulin attenuates beta-amyloid peptide 1-40 fibril formation and associated neurotoxicity of cultured fetal rat cortical neurons | Journal of Neurochemistry | 1998 | 86 |
| Regulation of amyloid precursor protein (APP) phosphorylation and processing by p35/Cdk5 and p25/Cdk5 | FEBS Letters | 2003 | 85 |
